Dr. Jonathan C. Cheng, MD, PhD

Dr. Cheng practices at David P Ellent in Spring, Texas.

Dr. Cheng's NPI, 1487824769, was assigned on March 3, 2008. Dr. Cheng graduated from Keck School of Medicine of USC in 2005. Dr. Cheng's Texas license number on file is N5619.

Dr. Cheng's primary practice is David P Ellent, at 2255 E Mossy Oaks Rd, Spring, TX 77389 in Harris County. The practice phone is (281) 440-5300.

Dr. Cheng's primary practice is David P Ellent in Spring, Texas. Dr. Cheng is also affiliated with Houston Methodist Baytown Hospital. The medical group on file is Genesis Medical Group. Dmand AI also links Dr. Cheng to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cheng is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Cheng's licenses on file in 8 states: Texas, South Carolina, California, Florida, Georgia, Kentucky, Maryland and Louisiana.

Dmand AI lists anal cancer radiation, bladder cancer radiation, breast cancer radiation, colorectal cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Cheng treats.

CMS data shows 4,494 Medicare services from Dr. Cheng across 19 procedure codes in 2024, for 190 Medicare patients. Medicare paid $549,389 for them. Every service was in an office.

CMS counts 190 Medicare patients who saw Dr. Cheng in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 72, with 27% women.

In 2024, Dr. Cheng wrote 305 Medicare Part D claims for 127 patients. 90% of them were for generic drugs. CMS names the drug for 181 of them, across 3 drugs with 11 or more claims each, at $2,588 in total drug cost. In 2023, CMS named 161 claims across 4 drugs.

Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth.

Dmand AI links 11 papers to Dr. Cheng, published from 2007 to 2024. The most frequent topics are DNA Methylation, Cytidine and DNA (Cytosine-5-)-Methyltransferases. Dr. Cheng has published most often in Int J Radiat Oncol Biol Phys. Dr. Cheng's most frequent co-authors are Jeffrey E. Wong, MD, Stephen J. Forman, MD and Gerrit V. Henry, D, IO.

CMS Open Payments shows 149 general payments to Dr. Cheng from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Elekta, Inc. paid the most, $50,639.

Dmand AI lists 9 awards for Dr. Cheng, most recently Chief Resident in 2010.

Dr. Cheng graduated from Keck School of Medicine of USC in 2005. Dr. Cheng is a member of ASTRO, ASCO and RSNA.

Dr. Cheng is in network with 19 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.